Hydrochloric Acid → N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide hydrochloride
Reaction equation
[ClH:1].[C:2]([C:4]1[C:5]([NH:36][CH2:37][CH2:38][O:39][CH3:40])=[CH:6][C:7]([NH:10][C:11]([N:13]2[C:22]3[C:17](=[CH:18][C:19]([CH2:28][N:29]4[CH2:34][CH2:33][NH:32][CH2:31][C:30]4=[O:35])=[C:20]([CH:23](OC)[O:24]C)[N:21]=3)[CH2:16][CH2:15][CH2:14]2)=[O:12])=[N:8][CH:9]=1)#[N:3]>C1COCC1.O>[ClH:1].[C:2]([C:4]1[C:5]([NH:36][CH2:37][CH2:38][O:39][CH3:40])=[CH:6][C:7]([NH:10][C:11]([N:13]2[C:22]3[C:17](=[CH:18][C:19]([CH2:28][N:29]4[CH2:34][CH2:33][NH:32][CH2:31][C:30]4=[O:35])=[C:20]([CH:23]=[O:24])[N:21]=3)[CH2:16][CH2:15][CH2:14]2)=[O:12])=[N:8][CH:9]=1)#[N:3]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
Concentrated hydrochloric acid (0.31 ml) was added to a solution of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-(dimethoxymethyl)-6-((2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide (intermediate 121, 250 mg, 0.371 mmol) in THF (10 ml) and water (2 ml) at room temperature. After stirring for 18 h at room temperature the reaction mixture was evaporated. The residue was purified by reversed phase HPLC (RP 2) to give the title compound.
Workup
- customwas evaporated
- customThe residue was purified by reversed phase HPLC (RP 2)
Sources & evidence
- ORD record
- ord-c93cd41803c2484d98245b602f89768e
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09266883B2
Reaction notes
Loading…